OrsoBio posts promising tirzepatide combo data

New findings suggest OrsoBio’s energy-burning approach could enhance tirzepatide’s effects while opening new possibilities for healthy aging. The next act after GLP-1s? US-based biopharma OrsoBio has a case. Obesity medicine has few unexpected transformations in recent years. Drugs such as tirzepatide have reshaped expectations around weight loss, helping millions of people achieve results once thought […] The post OrsoBio posts promising tirzepatide combo data appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.